Critical Juncture In Zolgensma EU Market Quest
Expensive And Controversial Gene Therapy Reaches CHMP
If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months.
If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months.